Molecular epidemiology of meticillin-resistant Staphylococcus aureus in Italian cystic fibrosis patients: A national overview

Journal of Cystic Fibrosis

Volumn 10, Issue 6, 2011, Pages 407-411

  Cocchi, P ^a   Cariani, L ^b   Favari, F ^b   Lambiase, A ^b   Fiscarelli, E ^b   Gioffre F V ^b   d'Aprile, A ^b   Manso, E ^b   Taccetti, G ^c   Braggion, C ^c   Doring G ^d   de Martino, M ^a   Campana, S ^c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Italian Cystic Fibrosis Microbiology Group   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

^d UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Cystic fibrosis; MLST; MRSA; SCCmec

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MINOCYCLINE; RIFAMPICIN; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM ISOLATION; GENOTYPE; HUMAN; ITALY; LUNG FIBROSIS; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN;

CYSTIC FIBROSIS; HUMANS; ITALY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCAL INFECTIONS;

EID: 81455158967     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2011.06.005     Document Type: Article

References (41)

1. Cystic Fibrosis Foundation Cystic Fibrosis Foundation patient registry: annual data report for 2009 2010, Bethesda, Maryland.
2. Sawicki G.S., Rasouliyan L., Pasta D.J., et al. The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis. Pediatr Pulmonol 2008, 43:1117-1123. For the investigators and coordinators of the epidemiologic study of cystic fibrosis.
3. 1 decline in cystic fibrosis. Am J Respir Crit Care Med 2008, 178:814-821.
4. Dasenbrook E.C., Checkley W., Merlo C.A., Konstan M.W., Lechtzin N., Boyle M.P. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA 2010, 303:2386-2392.
5. Döring G., Høiby N. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J Cyst Fibros 2004, 3:67-91. For the Consensus Study Group.
6. Vandenesh F., Naimi T., Enrigh M.C., et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003, 9:978-984.
7. Crawford S.E., Boyle-Vavra S., Daum R.S. Community-associated methicillin resistant Staphylococcus aureus. Emerging infections 2007, 153-179. ASM Press, Washington DC. W.M. Scheld, D.C. Hooper, J.M. Hughes (Eds.).
8. DeLeo F.R., Otto M., Kreiswirth N., Chambers H.F. Community-associated methicillin-resistant Staphylococcus aureus. Lancet 2010, 375:1557-1568.
9. Oliveira D.C., Milheriço C., de Lencastre H. Redefining a structural variant of Staphylococcal cassette chromosome mec, SCCmec type VI. Antimicrob Agents Chemother 2006, 50:3457-3459.
10. Chongtrakool P., Ito T., Ma X.X., et al. Staphylococcal cassette chromosome mec (SCCmec) typing of methicillin-resistant Staphylococcus aureus strains isolated in 11 Asian countries: a proposal for a new nomenclature for SCCmec elements. Antimicrob Agents Chemother 2006, 50:1001-1012.
11. Berglund C., Ito T., Ikeda M., Ma X.X., Söderquist B., Hiramatsu K. Novel type of staphylococcal cassette chromosome mec in a methicillin-resistant Staphylococcus aureus strain isolated in Sweden. Antimicrob Agents Chemother 2008, 52:3512-3516.
12. Zhang K., Mc Clure J.A., Elsayed S. Novel staphylococcal cassette chromosome mec type, tentatively designated type VIII, harboring class A mec and type 4 ccr gene complexes in a Canadian epidemic strain of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2009, 53:531-540.
13. Gillet Y., Sartel B., Vanhems, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine Leukocidin and highly lethal necrotizing pneumoniae in young immunocomponent patients. Lancet 2002, 359:753-759.
14. Campana S., Cocchi P., Döring G., Taccetti G., Moroney S.M. Emergence of an epidemic clone of community-associated methicillin-resistant Panton-Valentine leucocidin-negative Staphylococcus aureus in cystic fibrosis patient populations. J Clin Microbiol 2007, 45:3146.
15. Molina A., Del Campo R., Màiz L., et al. High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formation. J Antimicrob Chemother 2008, 62:961-967.
16. Elizur A., Orscheln R.C., Ferkol T.W., et al. Panton-Valentine Leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Chest 2007, 131:1718-1725.
17. Elizur A., Orscheln R.C., Ferkol T.W., Dunne W.M., Storch G.A., Cannon C.L. Transmission of Panton-Valentine leukocidin-positive Staphylococcus aureus between patients with cystic fibrosis. J Pediatr 2007, 151:90-92.
18. Stone A., Quittell L., Zhou J., et al. Staphylococcus aureus nasal colonization among pediatric cystic fibrosis patients and their household contacts. Pediatr Infect Dis J 2009, 28:895-899.
19. Vergison A., Denis O., Deplano A., et al. National survey of molecular epidemiology of Staphylococcus aureus colonization in Belgian cystic fibrosis patients. J Antimicrob Chemother 2007, 59:893-899.
20. Glikman D., Siegel J.D., David M.Z., et al. Complex molecular epidemiology of methicillin resistant Staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin resistant S. aureus. Chest 2008, 133:1381-1387.
21. Taccetti G., Cocchi P., Festini F., Braggion C., Campana S. Cystic fibrosis and community-associated meticillin-resistant Staphylococcus aureus. Lancet 2010, 376:767-768.
22. Oliveira D.C., de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant. Staphylococcus aureus Antimicrob Agents Chemother 2002, 46:2155-2161.
23. Zhang K., McClure J.A., Elsayed S., Louie T., Conly J.M. Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005, 43:5026-5033.
24. Lina G., Piemont Y., Godail-Gamot F., et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999, 29:1128-1132.
25. Walsh T.R., Bolmström A., Qwärnström A., Ho P., Wootton M., Howe A., et al. Evaluation of current methods for detection of Staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol 2001, 39:2439-2444.
26. Clinical and Laboratory Standard Institute Performance standards for antimicrobial disk susceptibility tests. Approved standard 2006, CLSI, Wayne, PA, Document M2-A9. 9th edition.
27. Enright M.C., Day N.P., Davies C.E., Peacock S.J., Spratt B.G. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000, 38:1008-1015.
28. Goodrich J.S., Sutton-Shields T.N., Kerr A., Wedd J.P., Miller M.B., Gilligan P.H. Prevalence of community-associated methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol 2009, 47:1231-1233.
29. Naimi T.S., LeDell K.H., Como-Sabetti K., et al. Comparison of community- and health care-associated methicillin resistant Staphylococcus aureus infection. JAMA 2003, 290:2976-2984.
30. Takano T., Higuchi W., Yamamoto T. Superior in vitro activity of carbapenems over anti-methicillin-resistant Staphylococcus aureus (MRSA) and some related antimicrobial agents for community-acquired MRSA but not for hospital-acquired MRSA. J Infect Chemother 2009, 15:54-57.
31. Liu Y., Kong F., Zhang X., Brown M., Ma L., Yang Y. Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in china from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous. Br J Dermatol 2009, 161:1347-1350.
32. Moore Z.S., Jerris R.C., Hilinski J.A. High prevalence of inducible clindamycin resistance among Staphylococcus aureus isolates from patients with cystic fibrosis. J Cyst Fibros 2008, 7:206-209.
33. David M.Z., Glikman D., Crawford S.E., et al. What is community-associated methicillin-resistant Staphylococcus aureus?. J Infect Dis 2008, 197:1235-1243.
34. Seybold U., Kourbatova E.V., Johnson J.G., et al. Emergence of community-associated methicillin-resistant Staphylococccus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006, 42:647-656.
35. Otter J.A., French G.L. The emergence of community-associated methicillin-resistant Staphylococccus aureus at London teaching hospital 2000-2006. Clin Microbiol Infect 2008, 14:670-676.
36. Manzur A., Dominguez A.M., Pujol M., et al. Community-acquired methicillin-resistant Staphylococcus aureus infections: an emerging threat in Spain. Clin Microbiol Infect 2008, 14:377-397.
37. Shibuya Y., Hara M., Higuchi W., Takano T., Iwao Y., Yamamoto T. Emergence of the community-acquired methicillin-resistant Staphylococcus aureus USA300 clone in Japan. J Infect Chemother 2008, 14:439-441.
38. Stefani S., Bongiorno D., Cafiso V., et al. Pathotype and susceptibility profile of a community-acquired methicillin-resistant Staphylococcus aureus responsible for a case of severe pneumoniae. Diagn Microbiol Infect Dis 2009, 63:100-104.
39. Marchese A., Gualco L., Maioli E., Debbia E. Molecular analysis and susceptibility patterns of meticillin-resistant Staphylococcus aureus (MRSA) strains circulating in the community in the Ligurian area, a northern region of Italy: emergence of USA300 and EMRSA-15 clones. Int J Antimicrob Agents 2009, 34:424-428.
40. Deurenberg R.H., Stobberingh E.E. The molecular evolution of hospital- and community-associated methicillin-resistant Staphylococcus aureus. Curr Mol Med 2009, 9:100-115.
41. Italian Cystic Fibrosis Foundation Website Impact on clinical status of cystic fibrosis patients of persistent lung infections with community acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) and hospital acquired methicillin-resistant Staphylococcus aureus (HA-MRSA): a multicenter longitudinal study. Principal Investigator Campana S Accessed May 22nd, 2011 at. http://www.fibrosicisticaricerca.it/Fibrosi-Cistica/Fibrosi-cistica.